| Name | Title | Contact Details |
|---|---|---|
Anne Digangi |
VP, Implementations & Strategic Integrations | Profile |
Outcomes4Me has developed an Artificial Intelligence (AI)-powered patient empowerment platform for shared decision-making between patients and providers. The platform harnesses regulatory-grade, real-world data and patient experiences to generate deeper insights that improve care, accelerate research and achieve better outcomes.
Open Source Health takes a truly patient-centered approach and is in the business of providing a real-time integrative healthcare solution for women in an open source architecture. Open Source Health is set to lead the current healthcare revolution by capitalizing on the latest trends in: digital health, personalized health, social health, mobile health, and participatory medicine.
Catasys leads the health care industry in improving health and reducing claims costs for health plan members with behavioral health disorders that cause or exacerbate co-existing medical conditions. OnTrak™, a 52-week intensive outpatient program, treats an overlooked population: members suffering from chronic disorders such as substance dependence, anxiety and depression who rarely seek care. These members cost health plans millions of medical dollars primarily due to preventable ambulance usage, medical ER visits and medical inpatient admissions. Catasys uses a proprietary analytics platform and predictive modeling to identify high utilizers of medical healthcare services with costs that can be significantly reduced by addressing the underlying behavioral health disorder(s). Through proactive outreach, we engage and treat these individuals in our patient-centric program that integrates evidence-based medical interventions, psychosocial skill building and care coaching by nurses.
Dedicated Distribution is a Kansas City, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Regional Nursing Services is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.